ABOUT: Marcinko Associates; Inc.

By Dr. David Edward Marcinko; MBA MEd CMP

PRACTICE MANAGEMENT AND FINANCIAL PLANNING ADVICE FOR MEDICAL PROFESSIONALS

***

***

At http://www.MarcinkoAssociates.com, we follow Fiduciary Standards for your protection:

Embrace the legal fiduciary obligation to place Medical colleague clients’ interests first

Deliver comprehensive financial planning and practice management advice for medical professionals

Provide fee-only advice; not fee-based advice

Do not accept commissions or assets under management

Be transparent on client costs, fees, and terms at all times

Provide transparency on portfolios and investment suggestions

Remain independent from any bank, broker dealer, insurance provider, RIA or custodian

Measure client performance returns using independent third parties

Do not create products to sell or price any public securities

Do not physically hold or possess any client assets, securities, or money for management

Investment and financial planning advice only!

OUR EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit a RFP for speaking engagements: MarcinkoAdvisors@outlook.com 

COMMENTS APPRECIATED

Read, Like, Refer and Subscribe

***

***

Safe Notes VERSUS Convertible Notes

By AI

***

***

What Is a SAFE Note?

A SAFE note is a type of convertible security that specifies a certain amount of money an investor will pay you as a business owner. In exchange, you agree to give the investor a certain amount of equity in your company at an agreed-upon future date. In other words, a SAFE note confers the right for an investor to purchase shares in your company in a future-priced round.

How SAFE Notes Work

According to ContractsCounsel, a SAFE note works in the following way:

  1. An investor provides funding in exchange for the right to future equity.
  2. You use the funding to grow your business.
  3. After your company grows sufficiently, you secure another investor, and your company receives a “post-money valuation.”
  4. You calculate your company’s price per share.
  5. You convert the SAFE note into the applicable number of shares and distribute them to the SAFE investor. Typically, a SAFE note converts after an equity financing round.

Example of a SAFE Note

An investor purchases a SAFE note with a valuation cap of $20 million. During the next funding round, the value of your company is set at $40 million at $20 a share. Because the SAFE note has a valuation cap of $20 million, its owner can purchase twice as many shares of your company as new investors can. This was the incentive for the SAFE investor to provide funding earlier.

What Is a CONVERTIBLE NOTE?

Within venture capital financing, a convertible note is a type of short-term debt financing that’s used in early-stage capital raises. In other words, convertible notes are loans to early-stage startups from investors who are expecting to be paid back when their note comes due. But, instead of being paid back in principal with interest—as would be the case with a typical loan—the investor can be repaid in equity in your company.

You might also think of a convertible note like an IOU. An investor provides you with capital now and the convertible note, acting as a short-term loan, ensures that you give the investor a stake in your startup later. From the investor’s point of view, the benefit in this exchange is that if they give you capital and a vote of confidence early on and you do well, you’ll repay them many times over.

How Do Convertible Notes Work?

Typically, an investor will provide an early-stage startup in need of capital with a loan (with repayment terms in the ballpark of a standard short-term loan, usually a year or two), along with repayment terms. This is the “note.” The note will include a due date at which time it’s mature and the balance will be due, along with interest. Generally, however, the note is not repaid like a normal short-term loan. Instead, you repay the investor for their loan with equity in your company, usually in conjunction with another funding round. 

If, however, the maturity date comes along and your startup has not yet converted the note to equity, the investor can either extend the convertible note’s maturity date or call for the actual repayment of the note.

Debt Paradox: https://medicalexecutivepost.com/2025/02/04/paradox-debt-may-be-necessary-to-build-wealth/

This being said, the whole idea behind convertible notes is that your company is on a strong growth trajectory and that is why the note is being issued—it amasses value for the investor and beelines to a priced round. Ultimately, the point of a convertible note is that the noteholder, or investor, doesn’t want to get their loan paid back— they want their debt to convert into a heavily discounted security in a successful, valuable company that’s growing extremely quickly.

Cons: The major downside of a convertible note is that you will eventually be giving up some control over your business. When the convertible note comes due, the investor will be granted equity in your business. If you’re not ready to split ownership of your business with outside parties, this is not the right financing option for you.

CASH ADVANCE LOANS: https://medicalexecutivepost.com/2024/12/14/merchant-cash-advance-loans/

COMMENTS APPRECIATED

Like and Refer

***

***

RIP: Robert Jarvik MD; 79

BREAKING NEWS!

By Staff Reporters

SPONSOR: http://www.CertifiedMedicalPlanner.org

***

***

Robert Jarvik, who developed the first artificial heart to be permanently implanted in a human — a breakthrough that captured the world’s imagination even as it triggered debates about medical ethics — died May 26th at his home in Manhattan, NY. He was 79.

Heart Attack: https://medicalexecutivepost.com/2021/01/08/heart-attack-symptoms/

The cause was complications from Parkinson’s disease, said his wife, writer Marilyn vos Savant.

MORE: https://en.wikipedia.org/wiki/Robert_Jarvik

COMMENTS APPRECIATED

Like and Refer

***

***

DAILY UPDATE: Home Prices and 23andMe as Stock Markets Wobble

MEDICAL EXECUTIVE-POST TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?
© Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2025

REFER A COLLEAGUE: MarcinkoAdvisors@outlook.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

Your Referral Count -0-

CITE: https://www.r2library.com/Resource

The median home price jumped 1.6% YoY last month and is sitting at $431,931. Meanwhile, mortgage rates for a 30-year fixed loan (the most common) are still hovering just under 7%. The chief economist of the National Association of Realtors said lower mortgage rates are the key to getting buyers to buy homes again.

CITE: https://tinyurl.com/2h47urt5

What’s up

  • Ulta Beauty is sitting pretty, up 11.78% after the cosmetics retailer crushed earnings expectations and raised its fiscal guidance for the year ahead.
  • Costco Wholesale rose 3.12% after beating Wall Street’s earnings expectations, though same-store sales did slip a bit.
  • Zscaler climbed 9.79% on strong earnings for the cybersecurity company, including 23% revenue growth.
  • Palantir popped 7.73% on a report from the New York Times that the Trump administration has asked the company to help the government compile data on US citizens.

What’s down

  • Nvidia slipped 2.92% as rhetoric between the US and China over semiconductor import restrictions reignited investor fears.
  • Gap plunged 20.18% after the retailer revealed that tariffs will cost between $100 and $150 million.
  • Marvell Technology fell 5.55% after the chip maker barely beat Wall Street expectations last quarter, failing to impress shareholders.
  • Regeneron Pharmaceuticals tumbled 19.01% thanks to mixed results for its new respiratory drug in late stage trials. The medication is made in partnership with Sanofi, which also dropped 5.61%.
  • Dell Technologies sank 2.08% after missing earnings expectations last quarter, though it did manage to beat on revenue.
  • Elastic NV beat analyst forecasts last quarter, but still fell 12.09% after the software company issued lower-than-expected revenue guidance.
  • PagerDuty, which is in fact a cloud computing company and not a seller of 1990s tech, lost 11.43% after issuing lower second-quarter guidance than Wall Street forecast.

CITE: https://tinyurl.com/tj8smmes

23andMe peaked at a $6 billion valuation in 2021 but never made a profit. It filed for bankruptcy on March 23rd and was put up for auction.

Visualize: How private equity tangled banks in a web of debt, from the Financial Times.

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@outlook.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***